Top

Published in:

01-05-2009 | Topic Review

Management options for cavernous sinus meningiomas

Authors: Michael T. Walsh, William T. Couldwell

Published in: Journal of Neuro-Oncology | Issue 3/2009

Abstract

Meningiomas involving the cavernous sinus have traditionally posed a major challenge for neurosurgeons and neuro-oncologists. Recent advancements in surgical techniques and radiotherapy have led to new treatment strategies for these difficult tumors. In this article, we review the current literature with respect to treatment options for cavernous sinus meningiomas. Additionally, we review the recent results of our experience at the University of Utah with decompression surgery followed by radiotherapy for cavernous sinus meningiomas.

Frotscher B (1910) Zur kasuistik der duraendotheliome. Arch Psychiatr Nervenkr 47:196–199. doi:10.1007/BF02322942 CrossRef

Cushing H, Eisenhardt L (1938) Meningiomas: their classification, regional behavior, life history and surgical end results. Charles C Thomas, Springfield

Parkinson D (1965) A surgical approach to the cavernous portion of the carotid artery. Anatomical studies and case report. J Neurosurg 23:474–483PubMed

Dolenc V (1979) Microsurgical removal of large sphenoidal bone meningiomas. Acta Neurochir Suppl (Wien) 28:391–396

Dolenc V (1989) Anatomy and surgery of the cavernous sinus. Springer-Verlag, New York

Kotapka MJ, Kalia KK, Martinez AJ, Sekhar LN (1994) Infiltration of the carotid artery by cavernous sinus meningioma. J Neurosurg 81:252–255PubMed

Larson JJ, van Loveren HR, Balko MG, Tew JM Jr (1995) Evidence of meningioma infiltration into cranial nerves: clinical implications for cavernous sinus meningiomas. J Neurosurg 83:596–599PubMed

Sen C, Hague K (1997) Meningiomas involving the cavernous sinus: histological factors affecting the degree of resection. J Neurosurg 87:535–543PubMed

Olivero WC, Lister JR, Elwood PW (1995) The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 83:222–224PubMed

10.

Go RS, Taylor BV, Kimmel DW (1998) The natural history of asymptomatic meningiomas in Olmsted County, Minnesota. Neurology 51:1718–1720PubMed

11.

Yano S, Kuratsu J (2006) Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 105:538–543. doi:10.3171/jns.2006.105.4.538 PubMedCrossRef

12.

Yoneoka Y, Fujii Y, Tanaka R (2000) Growth of incidental meningiomas. Acta Neurochir (Wien) 142:507–511. doi:10.1007/s007010050463 CrossRef

13.

Herscovici Z, Rappaport Z, Sulkes J, Danaila L, Rubin G (2004) Natural history of conservatively treated meningiomas. Neurology 63:1133–1134PubMed

14.

Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2003) The natural history of incidental meningiomas. Neurosurgery 53:62–70 (discussion 70–71)PubMedCrossRef

15.

Kuratsu J, Kochi M, Ushio Y (2000) Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92:766–770PubMed

16.

Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J (2000) Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 68:25–28. doi:10.1136/jnnp.68.1.25 PubMedCrossRef

17.

Sekhar LN, Sen CN, Jho HD, Janecka IP (1989) Surgical treatment of intracavernous neoplasms: a four-year experience. Neurosurgery 24:18–30. doi:10.1097/00006123-198901000-00004 PubMedCrossRef

18.

Ebner FH, Bornemann A, Wilhelm H, Ernemann U, Honegger J (2008) Tuberculum sellae meningioma symptomatic during pregnancy: pathophysiological considerations. Acta Neurochir (Wien) 150:189–193 (discussion 193)CrossRef

19.

Goldberg M, Rappaport ZH (1987) Neurosurgical, obstetric and endocrine aspects of meningioma during pregnancy. Isr J Med Sci 23:825–828PubMed

20.

Couldwell WT (2006) Asymptomatic meningiomas. J Neurosurg 105:536–537 (discussion 537)PubMedCrossRef

21.

Hirsch WL, Sekhar LN, Lanzino G, Pomonis S, Sen CN (1993) Meningiomas involving the cavernous sinus: value of imaging for predicting surgical complications. AJR Am J Roentgenol 160:1083–1088PubMed

22.

De Jesus O, Sekhar LN, Parikh HK, Wright DC, Wagner DP (1996) Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence, progression, and quality of life. Neurosurgery 39:915–919 (discussion 919–920)PubMedCrossRef

23.

DeMonte F, Smith HK, Al-Mefty O (1994) Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg 81:245–251PubMed

24.

Abdel-Aziz KM, Froelich SC, Dagnew E, Jean W, Breneman JC, Zuccarello M, van Loveren HR, Tew JM Jr (2004) Large sphenoid wing meningiomas involving the cavernous sinus: conservative surgical strategies for better functional outcomes. Neurosurgery 54:1375–1383 (discussion 1383–1384)PubMedCrossRef

25.

Sekhar LN, Patel S, Cusimano M, Wright DC, Sen CN, Bank WO (1996) Surgical treatment of meningiomas involving the cavernous sinus: evolving ideas based on a ten year experience. Acta Neurochir Suppl (Wien) 65:58–62

26.

Knosp E, Perneczky A, Koos WT, Fries G, Matula C (1996) Meningiomas of the space of the cavernous sinus. Neurosurgery 38:434–442 (discussion 442–444)PubMedCrossRef

27.

Sindou M, Wydh E, Jouanneau E, Nebbal M, Lieutaud T (2007) Long-term follow-up of meningiomas of the cavernous sinus after surgical treatment alone. J Neurosurg 107:937–944. doi:10.3171/JNS-07/11/0937 PubMedCrossRef

28.

Chang SD, Adler JR Jr, Martin DP (1998) LINAC radiosurgery for cavernous sinus meningiomas. Stereotact Funct Neurosurg 71:43–50. doi:10.1159/000029647 PubMedCrossRef

29.

Iwai Y, Yamanaka K, Ishiguro T (2003) Gamma knife radiosurgery for the treatment of cavernous sinus meningiomas. Neurosurgery 52:517–524 (discussion 523–524)PubMedCrossRef

30.

Lee JY, Niranjan A, McInerney J, Kondziolka D, Flickinger JC, Lunsford LD (2002) Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 97:65–72PubMed

31.

Liscak R, Simonova G, Vymazal J, Janouskova L, Vladyka V (1999) Gamma knife radiosurgery of meningiomas in the cavernous sinus region. Acta Neurochir (Wien) 141:473–480. doi:10.1007/s007010050327 CrossRef

32.

Roche PH, Regis J, Dufour H, Fournier HD, Delsanti C, Pellet W, Grisoli F, Peragut JC (2000) Gamma knife radiosurgery in the management of cavernous sinus meningiomas. J Neurosurg 93(suppl 3):68–73PubMed

33.

Shin M, Kurita H, Sasaki T, Kawamoto S, Tago M, Kawahara N, Morita A, Ueki K, Kirino T (2001) Analysis of treatment outcome after stereotactic radiosurgery for cavernous sinus meningiomas. J Neurosurg 95:435–439PubMed

34.

Spiegelmann R, Nissim O, Menhel J, Alezra D, Pfeffer MR (2002) Linear accelerator radiosurgery for meningiomas in and around the cavernous sinus. Neurosurgery 51:1373–1379 (discussion 1379–1380)PubMedCrossRef

35.

Abeloos L, Levivier M, Devriendt D, Massager N (2007) Internal carotid occlusion following gamma knife radiosurgery for cavernous sinus meningioma. Stereotact Funct Neurosurg 85:303–306. doi:10.1159/000107365 PubMedCrossRef

36.

Tishler RB, Loeffler JS, Lunsford LD, Duma C, Alexander EIII, Kooy HM, Flickinger JC (1993) Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 27:215–221PubMed

37.

Leber KA, Bergloff J, Pendl G (1998) Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88:43–50PubMed

38.

Couldwell WT, Cole CD, Al-Mefty O (2007) Patterns of skull base meningioma progression after failed radiosurgery. J Neurosurg 106:30–35. doi:10.3171/jns.2007.106.1.30 PubMedCrossRef

39.

Linskey ME, Davis SA, Ratanatharathorn V (2005) Relative roles of microsurgery and stereotactic radiosurgery for the treatment of patients with cranial meningiomas: a single-surgeon 4-year integrated experience with both modalities. J Neurosurg 102(suppl):59–70PubMed

40.

Couldwell WT, Kan P, Liu JK, Apfelbaum RI (2006) Decompression of cavernous sinus meningioma for preservation and improvement of cranial nerve function. Technical note. J Neurosurg 105:148–152. doi:10.3171/jns.2006.105.1.148 PubMedCrossRef

41.

Pamir MN, Kilic T, Bayrakli F, Peker S (2005) Changing treatment strategy of cavernous sinus meningiomas: experience of a single institution. Surg Neurol 64(suppl 2):S58–S66. doi:10.1016/j.surneu.2005.07.053 PubMedCrossRef

42.

Maruyama K, Shin M, Kurita H, Kawahara N, Morita A, Kirino T (2004) Proposed treatment strategy for cavernous sinus meningiomas: a prospective study. Neurosurgery 55:1068–1075. doi:10.1227/01.NEU.0000140839.47922.5A PubMedCrossRef

43.

van Loveren HR, Keller JT, El-Kalliny M, Scodary DJ, Tew JM Jr (1991) The Dolenc technique for cavernous sinus exploration (cadaveric prosection). Technical note. J Neurosurg 74:837–844PubMed

44.

Jensen RL, Wendland MM, Chern SS, Shrieve DC (2008) Novalis intensity-modulated radiosurgery: methods for pretreatment planning. Neurosurgery 62:A2–A9 (discussion A9–10)PubMedCrossRef

45.

Loven D, Hardoff R, Sever ZB, Steinmetz AP, Gornish M, Rappaport ZH, Fenig E, Ram Z, Sulkes A (2004) Non-resectable slow-growing meningiomas treated by hydroxyurea. J Neurooncol 67:221–226. doi:10.1023/B:NEON.0000021827.85754.8e PubMedCrossRef

46.

Newton HB, Scott SR, Volpi C (2004) Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up. Br J Neurosurg 18:495–499PubMedCrossRef

47.

Newton HB, Slivka MA, Stevens C (2000) Hydroxyurea chemotherapy for unresectable or residual meningioma. J Neurooncol 49:165–170. doi:10.1023/A:1026770624783 PubMedCrossRef

48.

Weston GJ, Martin AJ, Mufti GJ, Strong AJ, Gleeson MJ (2006) Hydroxyurea treatment of meningiomas: a pilot study. Skull Base 16:157–160. doi:10.1055/s-2006-949518 PubMedCrossRef

49.

Fuentes S, Chinot O, Dufour H, Paz-Paredes A, Metellus P, Barrie-Attarian M, Grisoli F (2004) Hydroxyurea treatment for unresectable meningioma. Neurochirurgie 50:461–467. doi:10.1016/S0028-3770(04)98326-9 PubMedCrossRef

50.

Grunberg SM, Weiss MH, Spitz IM, Ahmadi J, Sadun A, Russell CA, Lucci L, Stevenson LL (1991) Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 74:861–866PubMed

51.

Mason WP, Gentili F, Macdonald DR, Hariharan S, Cruz CR, Abrey LE (2002) Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. J Neurosurg 97:341–346PubMedCrossRef

52.

Schrell UM, Rittig MG, Anders M, Kiesewetter F, Marschalek R, Koch UH, Fahlbusch R (1997) Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 86:845–852PubMedCrossRef

53.

Ragel BT, Couldwell WT, Wurster RD, Jensen RL (2007) Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas. Neurosurg Focus 23(4):E10. doi:10.3171/FOC-07/10/E10 PubMedCrossRef

54.

Ragel BT, Gillespie DL, Kushnir V, Polevaya N, Kelly D, Jensen RL (2006) Calcium channel antagonists augment hydroxyurea- and RU486-induced inhibition of meningioma growth in vivo and in vitro. Neurosurgery 59:1109–1120 (discussion 1120–1121)PubMedCrossRef

55.

Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2005) Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J Neurosurg 103:508–517PubMed

56.

Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2007) Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer 109:588–597. doi:10.1002/cncr.22441 PubMedCrossRef

57.

Kaba SE, DeMonte F, Bruner JM, Kyritsis AP, Jaeckle KA, Levin V, Yung WK (1997) The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B. Neurosurgery 40:271–275. doi:10.1097/00006123-199702000-00007 PubMedCrossRef

58.

Koper JW, Zwarthoff EC, Hagemeijer A, Braakman R, Avezaat CJ, Bergstrom M, Lamberts SW (1991) Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha. Eur J Cancer 27:416–419PubMed

59.

Wober-Bingol C, Wober C, Marosi C, Prayer D (1995) Interferon-alfa-2b for meningioma. Lancet 345:331. doi:10.1016/S0140-6736(95)90326-7 PubMedCrossRef

60.

Arena S, Barbieri F, Thellung S, Pirani P, Corsaro A, Villa V, Dadati P, Dorcaratto A, Lapertosa G, Ravetti JL, Spaziante R, Schettini G, Florio T (2004) Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity. J Neurooncol 66:155–166. doi:10.1023/B:NEON.0000013498.19981.55 PubMedCrossRef

61.

Chamberlain MC, Glantz MJ, Fadul CE (2007) Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology 69:969–973. doi:10.1212/01.wnl.0000271382.62776.b7 PubMedCrossRef

62.

Schulz S, Pauli SU, Handel M, Dietzmann K, Firsching R, Hollt V (2000) Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res 6:1865–1874PubMed

63.

Johnson MD, Sade B, Milano MT, Lee JH, Toms SA (2008) New prospects for management and treatment of inoperable and recurrent skull base meningiomas. J Neurooncol 86:109–122. doi:10.1007/s11060-007-9434-z PubMedCrossRef

Title: Management options for cavernous sinus meningiomas
Authors: Michael T. Walsh
William T. Couldwell
Publication date: 01-05-2009
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2009
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-009-9824-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Management options for cavernous sinus meningiomas

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2009

Odyssey of hope: a physician’s guide to communicating with brain tumor patients across the continuum of care

Intraoperative optical identification of pituitary adenomas

Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and long-term results using the Gamma Knife

Emerging functions of microRNAs in glioblastoma

Current concepts in the evaluation and management of WHO grade II gliomas

Surgical management of craniopharyngiomas